The first ALS patient has been enrolled in an NIH-funded expanded access program trial evaluating MN-166 (ibudilast).

Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...

MS patients in rural areas are 17% less likely to receive DMTs than those in urban areas, a study of Alberta, Canada, ...

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 ...

NHS England’s top cancer doctor says we should be checking for these changes in our body at least once every three weeks - as ...

A recent setback hasn't stopped Donald Frank from trying to obtain compensation from a billion-dollar fund the NFL ...

Poor communication contributed to 24.0% of safety incidents in 42 studies that examined its contribution along with other causes.

Researchers at Queen Mary University of London previously discovered that drinking a glass of one juice per day could help ...

Researchers at Queen Mary University of London previously discovered that drinking a glass of one juice per day could help ...

The NHS is encouraging the public to perform regular body checks for potential signs of cancer, ideally every three weeks.

The CT Clinical Innovation Center at Mayo Clinic has a robust roster of faculty, staff and alumni committed to advancing CT imaging technology and methods to reduce radiation doses.